Efedra Pharmaceuticals Private Limited, a active private limited company, was established on 08 December 2017 in Kolkata, West Bengal, India. Engaging in drug formulation & development within the hospital and medical care sector, it holds CIN: U24239WB2017PTC223778. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.30 M.
It upholds a compliant status. Employing 26 professional, Its leadership includes Arindam Bhattacharya (Director), Mohuya Chakroborty (Director), Swati Roy (Additional Director). It holds ₹1.72 Cr open charges and no settled loans. Its latest AGM occurred on 25 September 2024, with the balance sheet filed on 31 March 2024. It is based at 306 Ajay Nagar, Kolkata, West Bengal, 700075.
U24239WB2017PTC223778
223778
08 December 2017
₹1.50 M
₹0.30 M
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Efedra Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arindam Bhattacharya | Director | 08 Dec 2017 | Current |
| Mohuya Chakroborty | Director | 08 Dec 2017 | Current |
| Swati Roy | Additional Director | 11 Jul 2025 | Current |
| Kaustav Mandal | Additional Director | 28 Oct 2025 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Efedra Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 67.6% increase. The company also saw a substantial fall in profitability, with a 27.34% decrease in profit. The company's net worth Soared by an impressive increase of 48.12%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Efedra Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹17,200,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jul 2025 | State Bank Of India | ₹1.72 Cr | Open |
Explore comprehensive loan charge details -
Efedra Pharmaceuticals has a workforce of 26 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Efedra Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Efedra Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Kaustav Mandal was appointed as a Additional Director was appointed as a Additional Director on 28 Oct 2025 & has been associated with this company since 1 month 27 days . was documented.
Progress on A charge with State Bank Of India amounted to Rs. 17.20 M with Charge ID 101127615 was registered on 11 Jul 2025. was documented.
The activity Swati Roy was appointed as a Additional Director was appointed as a Additional Director on 11 Jul 2025 & has been associated with this company since 5 months 16 days . was completed.
Efedra Pharmaceuticals Private Limited last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records. was recorded as a recent event.
Efedra Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was recorded as a recent event.
Arindam Bhattacharya was appointed as a Director was appointed as a Director on 08 Dec 2017 & has been associated with this company since 8 years 17 days . was recorded as a recent event.
The CIN of Efedra Pharmaceuticals Private Limited is U24239WB2017PTC223778.
Efedra Pharmaceuticals Private Limited is headquartered at 306 Ajay Nagar, Kolkata, West Bengal, 700075.
Efedra Pharmaceuticals Private Limited was incorporated on 08 December 2017.
The current directors of Efedra Pharmaceuticals Private Limited are
The primary industry of Efedra Pharmaceuticals Private Limited is Hospital And Medical Care.
Efedra Pharmaceuticals Private Limited is unlisted.
The authorized capital of Efedra Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹0.30 M.
The compliance status of Efedra Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX